SpielmannH., PohlI., DöringB., LiebschM., & MoldenhauerF. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. Toxicology in Vitro10, 119–127.
2.
Anon. (2002). INVITTOX Protocol 113: Embryonic Stem Cell Test (EST). ECVAM SIS Database. 34 pp. Ispra, Italy: ECVAM, European Commission JRC. Website http://ecvam-sis.jrc.it (Accessed 30.09.04).
3.
ScholzG., GenschowE., PohlI., BremerS., PaparellaM., RaabeH., MoldenhauerF., SoutheeJ.A., & SpielmannH. (1999). Prevalidation of the Embryonic Stem Cell Test (EST), a new in vitro embryotoxicity test. Toxicology in Vitro13, 675–681.
4.
GenschowE., ScholzG., BrownN., PiersmaA., BradyM., ClemannN., HuuskonenH., PaillardF., BremerS., BeckerK., & SpielmannH. (2000). Development of prediction models for three in vitro embryotoxicity tests. In Vitro and Molecular Toxicology13, 51–65.
5.
GenschowE., SpielmannH., ScholzG., SeilerA., BrownN.A., PiersmaA., BradyM., ClemannN., HuuskonenH., PaillardF., BremerB., & BeckerK. (2002). The ECVAM international validation study on in vitro embryotoxicity tests. Results of the definitive phase and evaluation of prediction models. ATLA30, 151–176.
6.
GenschowE., SpielmannH., ScholzG., PohlI., SeilerA., ClemannN., BremerS., & BeckerK.Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA32, 209–244.
7.
Anon. (2002). INVITTOX Protocol 72: Rat Whole Embryo Culture (WEC). ECVAM SIS Database. 12 pp. Ispra, Italy: ECVAM, European Commission JRC. Website http://ecvam-sis.jrc.it (Accessed 30.09.04).
8.
NewD.A.T. (1978). Whole embryo culture and the study of mammalian embryos during organogenesis. Biological Reviews of the Cambridge Philosophical Society53, 81–122.
9.
BrownN.A., & FabroS. (1981). Quantification of rat embryonic development in vitro: a morphological scoring system. Teratology24, 65–78.
10.
BechterR., & SchmidB.P. (1987). Teratogenicity in vitro. A comparative study of four antimycotic drugs using the whole embryo culture system. Toxicology in Vitro1, 11–15.
11.
PiersmaA.H., BechterR., KrafftN., SchmidB.P., StadlerJ., VerhoefA., VerseilC., & ZijlstraJ. (1996). An interlaboratory evaluation of five pairs of teratogens and non-teratogens in post-implantation rat embryo culture. ATLA24, 201–209.
12.
SadlerT.W., HortonW.E., & WarnerC.W. (1982). Whole embryo culture: a screening technique for teratogensvarious. Teratogenesis, Carcinogenesis and Mutagenesis2, 243–253.
13.
PiersmaA.H., GenschowE., VerhoefA., SpanjersbergM., BrownN.A., BradyM., BurnsA., ClemannN., SeilerA., & SpielmannH. (2004). Validation of the rat postimplantation whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA32, 275–307.
14.
Anon. (2002). INVITTOX Protocol 114: The Micromass In Vitro Embryotoxicity Test. ECVAM SIS Database. 12 pp. Ispra, Italy: ECVAM, European Commission JRC. Website http://ecvam-sis.jrc.it (Accessed 30.09.04).
15.
BrownN.A., SpielmannH., BechterR., FlintO.P., FreemanS.J., JelinekR.J., KochE., NauH., NewallD.R., PalmerA.K., RenaultJ.Y., RepettoM.F., VogelR., & WigerR. (1995). Screening chemicals for reproductive toxicity: the current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM Workshop 12). ATLA23, 869–882.
16.
FlintO.P. (1980). The effects of sodium salicylate, cytosine arabinoside and eserine sulphate on rat limb buds in culture. In Teratology of the Limb (ed. MerkerH.J., NauH., & NeubertD.), pp. 325–338. Berlin, Germany: Walter de Gruyter and Co.
17.
FlintO.P. (1983). A micromass culture method for rat embryonic neural cells. Journal of Cell Science61, 247–262.
18.
FlintO.P. (1987). An in vitro test for teratogens using cultures of rat embryo cells. In In Vitro Methods in Toxicology (ed. AtterwillC.K., & SteeleC.E.), pp. 339–363. Cambridge, UK: Cambridge University Press.
19.
FlintO.P., & OrtonT.C. (1984). An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells. Toxicology and Applied Pharmacology76, 383–395.
20.
FreemanS.J., & BrownN.A. (1987). Sub-mammalian and sub-vertebrate models in teratogenicity screening. In In Vitro Methods in Toxicology ed. (AtterwillC.K., & SteeleC.E.), pp. 391–409. Cambridge, UK: Cambridge University Press.
21.
RockleyJ., & RicholdM. (1990). In vitro micromass teratogen test: interpretation of results from a blind trial of 25 compounds using three separate criteria. Toxicology in Vitro4, 609–611.
22.
PetersP.W.J., & PiersmaA.H. (1990). In vitro embryotoxicity and teratogenicity studies. Toxicology in Vitro4, 570–576.
23.
UphillP.F., WilkinsS., & AllenJ.A. (1990). In vitro micromass teratogen test: results from a blind trial of 25 compounds. Toxicology in Vitro4, 623–626.
24.
WhittakerS.G., & FaustmanE.M. (1994). In vitro assays for developmental toxicity. In In Vitro Toxicology (ed. Cox GadS.), pp. 97–122. New York, NY, USA: Raven Press.
25.
SpielmannH., GenschowE., BrownN.A., PiersmaA.H., VerhoefA., SpanjersbergM., HuuskonenH., PaillardF., & SeilerA. (2004). Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA32, 245–274.
26.
CookeB.A., LindhL.M., & Van der MolenH.J. (1979). The mechanism of action of lutropin on regulator protein(s) involved in Leydig-cell steroidogenesis. Biochemical Journal184, 33–38.
27.
KoizumiT., & LiZ.G. (1992). The role of oxidative stress in single dose cadmium induced testicular cancer. Journal of Toxicology and Environmental Health37, 25–36.
28.
ChaudharyL.R., & StoccoD.M. (1989). Inhibition of hCG- and cAMP-stimulated progesterone production in MA-10 mouse Leydig tumor cells by ketoconazole. Biochemistry International18, 251–262.
29.
EnglishH.F., SanterS.J., LevineH.B., & SantenR.J. (1989). Inhibition of testosterone production with ketoconazole alone and in combination with a gonadotrophin releasing hormone analogue in the rat. Cancer Research46, 38–42.
30.
WalshL.P., McCormickC., MartinC., & StoccoD.M. (2000). Roundup inhibits steroidogenesis by disrupting steroidogenic acute regulatory (StAR) protein expression. Environmental Health Perspectives108, 769–776.
31.
RommertsF.F.G., TeerdsK.J., & HoogerbruggeJ.W. (1988). In vitro effects of ethylene-dimethane sulfonate (EDS) on Leydig cells: inhibition of steroid production and cytotoxic effects are dependent on species and age of rat. Molecular and Cellular Endocrinology55, 87–94.
32.
MolenaarR., de RooijD.G., RommertsF.F., ReuversP.J., & van der MolenH.J. (1985). Specific destruction of Leydig cells in mature rats after in vivo administration of ethane dimethyl sulfonate. Biology of Reproduction33, 1213–1222.
33.
GangoliS.D. (1982). Testicular effects of phthalate esters. Environmental Health Perspectives45, 77–84.
34.
DeesJ.H., GazouliM., & PapadopoulosV. (2001). Effect of mono-ethylhexyl phthalate on MA-10 Leydig tumor cells. Reproductive Toxicology15, 171–187.
35.
SonnenscheinC., & SotoA.M. (1998). An updated review of environmental estrogen and androgen mimics and antagonists. Journal of Steroid Biochemistry and Molecular Biology65, 143–150.
36.
NikulaH., TalonpoikaT., KalevaM., & ToppariJ. (1999). Inhibition of hCG-stimulated steroidogenesis in cultured mouse Leydig tumor cells by bisphenol A and octylphenols. Toxicology and Applied Pharmacology157, 166–173.
StonerE. (1990). The clinical development of a 5 alpha reductase inhibitor, finasteride. Journal of Steroid Biochemistry and Molecular Biology37, 375–378.
39.
SullivanM.H., & CookeB.A. (1984). The effect of calcium on the potentiation of LH-stimulated steroidogenesis and inhibition of LH-stimulated cyclic AMP production by LHRH agonist (ICI 118630) in rat Leydig cells. Molecular and Cellular Endocrinology34, 17–22.
40.
CleggE.D., CookJ.C., ChapinR.E., FosterP.M.D., & DastonG.P. (1997). Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans. Reproductive Toxicology11, 107–121.
41.
CortvrindtR., SmitzJ., & Van SteirteghemA.C. (1996). In-vitro maturation, fertilization and embryo development of immature oocytes from early pre-antral follicles from prepubertal mice in a simplified culture system. Human Reproduction11, 2656–2666.
42.
CortvrindtR., SmitzJ., & Van SteirteghemA.C. (1997). Assessment of the need for follicle stimulating hormone in early pre-antral mouse follicle in vitro culture. Human Reproduction12, 759–768.
43.
CortvrindtR., & SmitzJ. (1998). Early preantral mouse follicle in-vitro maturation: oocyte growth, meiotic maturation and granulosa-cell proliferation quantified. Theriogenology49, 845–859.
44.
CortvrindtR., HuY., LiuJ., & SmitzJ. (1998). Timed analysis of the nuclear maturation of oocytes in recombinant gonadotropin-supplemented early preantral mouse follicle culture. Fertility and Sterility70, 1114–1125.
45.
CortvrindtR., & SmitzJ. (2002). Follicle culture in reproductive toxicology: a tool for in vitro testing of ovarian function?Human Reproduction Update8, 243–254.
46.
HuY., CortvrindtR., & SmitzJ. (2002). Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Molecular Reproduction and Development61, 549–559.
47.
SandersonJ.T., SeinenW., GiesyJ.P., & van denB.M. (2000). 2-Chloro-s-triazine herbicides induce aromatase (CYP 19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estogenicity. Toxicological Sciences54, 121–127.
48.
PelisseroC., LenczowskiM.J., ChinziD., DavailcussitB., SumpterJ.P., & FostierA. (1999). Effects of flavonoids on aromatase activity: an in vitro study. Journal of Steroid Biochemistry70, 249–256.
49.
RobertsonK.M., O'DonellJ.M.E., MeachemS.J., BoonW.C., FisherC.R., GravesK.H., MclachlanR.I., & SimpsonE.R. (1999). Impairment of spermatogenesis in mice lacking a functional aromatase (Cyp 19) gene. Proceedings of the National Academy of Sciences USA96, 7986–7991.
50.
KellisJ.T., & VickeryL.E. (1987). Purification and characterization of human placental aromatase cytochrome P-450. Journal of Biological Chemistry262, 4413–4420.
51.
MeansG.D., KilgoreM.W., MahedrooM.S., MendelsonC.R., & SimpsonE.R. (1991). Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Molecular Endocrinology5, 2005–2013.
52.
StresserD.M., TurnerS.D., McNamaraJ., StockerP., MillerV.P., CrespiC.L., & PattenC.J. (2000). A high-throughput screen to identify inhibitors of aromatase (CYP 19). Analytical Biochemistry284, 427–430.
53.
IbrahimA.R., & Abul-HajiY.J. (1990). Aromatase inhibition by flavonoids. Journal of Steroid Biochemistry and Molecular Biology37, 257–260.
54.
VinggaardA.M., HnidaC., BreinholdtV., & LarsonJ.C. (2000). Screening of selected pesticides for inhibition of CYP19 in vitro.Toxicology in Vitro14, 227–234.
55.
BueggemeierR.W., & KatlicN.E. (1990). Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures. Cancer Research50, 3652–3656.
56.
LetcherR.J., DrenthH.J., NorstromR.J., BergmanA., SafeS., & PietersR. (1999). Cytotoxicity and aromatase (CYP 19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells. Toxicology and Applied Pharmacology160, 10–20.
57.
AschmannC., StorkT., & WassermannO. (1989). Short-term effects of chlorophenols on the function and viability of primary cultured rat hepatocytes. Archives of Toxicology63, 121–126.
58.
BabichH., & BorenfreundE. (1987). In vitro cytotoxicity of organic pollutants to bluegill sunfish (BF-2) cells. Environmental Research42, 229–237.
59.
EkwallB., SellingJ., & JohnelsD. (1987). Toxicity of chlorophenols to HeLA cells as measured in the MIT-24 system. ATLA14, 178–181.
60.
GüldenM., & BurghoffC. (1990). Effects of membrane directed neurotoxicants on the contractile activity of cultured skeletal muscle cells. ATLA17, 215–217.
61.
HongC.Y., Chaput de SaintongeD.M., & TurnerP. (1981). A simple method to measure drug effects on human spermatozoa motility. British Journal of Clinical Pharmacology11, 385–387.
62.
KolossaM., & SeibertH. (1990). A chemically “defined” diluent for cryopreservation of bovine spermatozoa. Andrologia22, 445–454.
63.
SeibertH. (1988). Messung der Bewegungsaktivität der Spermatozen von Mensch und Rind mit Hilfe von Videomikrographie und Computerbildanalyse. Fertilität4, 215–218.
64.
SeibertH., KolossaM., & WassermanO. (1989). Bovine spermatozoa as an in vitro model for studies on the cytotoxicity of chemicals: effects of chlorophenols. Cell Biology and Toxicology5, 315–330.
65.
SeibertH., & GoschU. (1990). A short-term bovine sperm cell assay for the evaluation of the in vitro cytotoxicity of chemicals. ATLA17, 228–232.
66.
TessereauxI., GüldenM., & WassermannO. (1987). Cultured myotubes from skeletal muscle of adult rats. Characterization and action of Anemonia sulcata toxin. II. Naunyn-Schmiedeberg's Archives of Pharmacology336, 232–239.
67.
VossJ.U., & SeibertH. (1991). Microcarrier-attached rat hepatocytes as a xenobiotic-metabolizing system in cocultures. Cell Biology and Toxicology7, 387–399.
68.
WHO (1987). WHO Laboratory Manual for the Examination of Human Semen and Semen-cervical Mucus Interaction, 138 pp. Cambridge, UK: Cambridge University Press.
69.
WeissD.G. (1989). Videomicroscopic measurements in living cells: dynamic determination of multiple endpoints for in vitro toxicology. Journal of Molecular Toxicology1, 465–488.
70.
FrancavillaF., SantucciR., MacerolaB., RuvoloG., & RomanoR. (2000). Nitric oxide synthase inhibition in human sperm affects sperm-oocyte fusion but not zona pellucida binding. Biology of Reproduction63, 425–429.
71.
FrancavillaF., RomanoR., SantucciR., MacerolaB., RuvoloG., & FrancavillaS. (2002). Effect of human sperm exposure to progesterone on sperm-oocyte fusion and sperm-zona pellucida binding under various experimental conditions. International Journal of Andrology25, 106–112.
72.
ZahalskyM.P., ZoltanE., MedleyN., & NaglerH.M. (2003). Morphology and the sperm penetration assay. Fertility and Sterility79, 39–41.
73.
CuligZ., HobischA., BartschG., & KlockerH. (2000). Androgen receptor: an update of mechanisms of action in prostate cancer. Urological Research28, 211–219.
74.
ElsbyR., MaggsJ.L., AshbyJ., PatonD., SumpterJ.P., & ParkB.K. (2001). Assessment of the effects of metabolism on the estrogenic activity of xenoestrogens: a two-stage approach coupling human liver microsomes and a yeast estrogenicity assay. Journal of Pharmacology and Experimental Therapeutics296, 329–337.
75.
RamamoorthyK., WangF., ChenI.C., NorrisJ.D., McDonnellD.P., LeonardL.S., GaidoK.W., BocchinfusoW.P., KorachK.S., & SafeS. (1997). Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism. Endocrinology138, 1520–1527.
76.
ArcaroK.F., YiL., SeegalR.F., VakhariaD.D., YangY., SpinkD.C., BroschK., & GierthyJ.F. (1999). 2,2'6,6’-Tetrachlorobiphenyl is estrogenic in vitro and in vivo.Journal of Cellular Biochemistry72, 94–102.
77.
BrooksS.C., HansenE.R., SaundersD.E., BattelliM.G., & ShafieS.M. (1984). Effect of growth on the estrogen receptor levels in MCF-7 cells. Cancer Research44, 3724–3729.
78.
DodgeJ.A., GlasebrookA.L., MageeD.E., PhillipsD.L., SatoM., ShortL.L., & BryantH.U. (1996). Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat. Journal of Steroid Biochemistry and Molecular Biology59, 155–161.
79.
KramerV.J., HelferichW.G., BergmanÅ., Klasson-WehlerE., & GiesyJ.P. (1997). Hydroxylated polychlorinated biphenyl metabolites are antiestrogenic in a stably transfected human breast adenocarcinoma (MCF7) cell line. Toxicology and Applied Pharmacology144, 363–376.
80.
LascombeI., BeffaD., RueggU., TarradellasJ., & WahliW. (2000). Estrogenic activity assessment of environmental chemicals using in vitro assays: identification of two new estrogenic compounds. Environmental Health Perspectives108, 621–629.
81.
MiodiniP., FioravantiL., Di FronzoG., & CappellettiV. (1999). The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. British Journal of Cancer80, 1150–1155.
82.
NagelS.C., vom SaalF.S., ThayerK.A., DharM.G., BoechlerM., & WelshonsW.V. (1997). Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environmental Health Perspectives105, 70–76.
83.
PalominoE., HeegM.J., HorwitzJ.P., PolinL., & BrooksS.C. (1994). Skeletal conformations and receptor binding of some 9,11-modified estradiols. Journal of Steroid Biochemistry and Molecular Biology50, 75–84.
84.
RijksL.J., BoerG.J., EndertE., de BruinK., van den BosJ.C., van DoremalenP.A., SchoonenW.G., JanssenA.G., & van RoyenEA. (1996). The stereoisomers of 17alpha-[123I]iodovinyloestradiol and its 11beta-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats. European Journal of Nuclear Medicine23, 295–307.
85.
StoesselS., & LeclercqG. (1986). Competitive binding assay for estrogen receptor in monolayer culture: measure of receptor activation potency. Journal of Steroid Biochemistry25, 677–682.
86.
VanderKuurJ.A., WieseT., & BrooksS.C. (1993). Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex. Biochemistry32, 7002–7008.
87.
SotoA.M., SonnenscheinC., ChungK.L., FernandezM.F., OleaN., & SerranoF.O. (1995). The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environmental Health Perspectives103, 113–122.
88.
ArcaroK.F., YangY., VakhariaD.D., & GierthyJ.F. (2000). Toxaphene is antiestrogenic in a human breast-cancer cell assay. Journal of Toxicology and Environmental Health — Part A59, 197–210.
89.
GaidoK.W., LeonardL.S., ManessS.C., HallJ.M., McDonnellD.P., SavilleB., & SafeS. (1999). Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology140, 5746–5753.
90.
KlotzD.M., BeckmanB.S., HillS.M., McLachlanJ.A., WaltersM.R., & ArnoldS.F. (1996). Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environmental Health Perspectives104, 1084–1089.
91.
KraichelyD.M., SunJ., KatzenellenbogenJ.A., & KatzenellenbogenB.S. (2000). Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology141, 3534–3545.
92.
MeyersM.J., SunJ., CarlsonK.E., KatzenellenbogenB.S., & KatzenellenbogenJ.A. (1999). Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis-and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochry-senes. Journal of Medicinal Chemistry42, 2456–2468.
93.
SunJ., MeyersM.J., FinkB.E., RajendranR., KatzenellenbogenJ.A., & KatzenellenbogenB.S. (1999). Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology140, 800–804.
94.
VakhariaD.D., & GierthyJ.F. (2000). Use of a combined human liver microsome-estrogen receptor binding assay to assess potential estrogen modulating activity of PCB metabolites. Toxicology Letters114, 55–65.
95.
FertuckK.C., KumarS., SikkaH.C., MatthewsJ.B., & ZacharewskiT.R. (2001). Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor. Toxicology Letters121, 167–177.
96.
BolgerR., WieseT.E., ErvinK., NestichS., & ChecovichW. (1998). Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environmental Health Perspectives106, 551–557.
97.
HaniokaN., JinnoH., Tanaka-KagawaT., NishimuraT., & AndoM. (1999). In vitro metabolism of simazine, atrazine and propazine by hepatic cytochrome P450 enzymes of rat, mouse and guinea pig, and oestrogenic activity of chlorotriazines and their main metabolites. Xenobiotica29, 1213–1226.
98.
HashimotoY., & NakamuraM. (2000). Estrogenic activity of dental materials and isphenol-A related chemicals in vitro.Dental Materials Journal19, 245–262.
99.
NikovG.N., HopkinsN.E., BoueS., & AlworthW.L. (2000). Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environmental Health Perspectives108, 867–872.
100.
NikovG.N., EsheteM., RajnarayananR.V., & AlworthW.L. (2001). Interactions of synthetic estrogens with human estrogen receptors. Journal of Endocrinology170, 137–145.
101.
ParkerG.J., LawT.L., LenochF.J., & BolgerR.E. (2000). Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. Journal of Biomolecular Screening5, 77–88.
102.
SaitoK., TomigaharaY., OheN., IsobeN., NakatsukaI., & KanekoH. (2000). Lack of significant estrogenic or antiestrogenic activity of pyrethroid insecticides in three in vitro assays based on classic estrogen receptor alpha-mediated mechanisms. Toxicological Sciences57, 54–60.
TilleyW.D., MarcelliM., WilsonJ.D., & McPhauM.J. (1989). Characterization and expression of a cDNA encoding the human androgen receptor. Proceedings of the National Academy of Sciences USA86, 327–331.
105.
WilsonV.S., BobseineK., LambrightC.R., & GrayL.E.Jr. (2002). A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences66, 69–81.
106.
WilsonE.M., & FrenchF.S. (1976). Binding properties of androgen receptors: evidence for identical receptors in rat testis, epididymis, and prostate. The Journal of Biological Chemistry251, 5620–5629.
107.
KemppainenJ.A., & WilsonE.M. (1996). Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization. Urology48, 157–163.
108.
KemppainenJ.A., LaneM.V., SarM., & WilsonE.M. (1992). Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation: specificity for steroids and antihormones. Journal of Biological Chemistry267, 968–974.
109.
KemppainenJ.A., LangleyE., WongC.I., BobseineK., KelceW.R., & WilsonE.M. (1999). Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Molecular Endocrinology13, 440–454.
110.
TakeoJ., & YamashitaS. (2000). Rainbow trout androgen receptor-α fails to distinguish between any of the natural androgens tested in transactivation assay, not just 11-ketotestosterone and testosterone. General and Comparative Endocrinology117, 200–206.
111.
BrownT.R., RothwellS.W., SultanC., & MigeonC.J. (1981). Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens. Steroids37, 635–648.
112.
VinggaardA.M., BreinholtV., & LarsenJ.C. (1999). Screening of selected pesticides for oestrogen receptor activation in vitro.Food Additives and Contaminants16, 533–542.
ManessS.C., McDonnellD.P., & GaidoK.W. (1998). Inhibition of androgen receptor-dependent transcriptional activity by DDT isomers and methoxychlor in HepG2 human hepatoma cells. Toxicology and Applied Pharmacology151, 135–142.
115.
TamuraH., ManessS.C., ReischmannK., DormanD.C., GrayL.E., & GaidoK.W. (2001). Androgen receptor antagonism by the organophosphate insecticide fenitrothion. Toxicological Sciences60, 56–62.
116.
LambrightC., OstbyJ., BobseineK., WilsonV., HotchkissA.K., MannP.C., & GrayL.E.Jr. (2000). Cellular and molecular mechanisms of action of linuron: an antiandrogenic herbicide that produces reproductive malformations in male rats. Toxicological Sciences56, 389–399.
117.
HartigP.C., BobseineK.L., BrittB.H., CardonM.C., LambrightC.R., WilsonV.S., & GrayL.E.Jr. (2002). Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening. Toxicological Sciences66, 82–90.
van DortM.E., RobinsD.M., & WayburnB. (2000). Design, synthesis, and pharmacological characterization of 4-[4,4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]-2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand. Journal of Medical Chemistry43, 3344–3347.
120.
SultanC., BalaguerP., TerouanneB., GeorgetV., ParisF., JeandelC., LumbrosoS., & NicolasJ. (2001). Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation. Molecular and Cellular Endocrinology178, 99–105.
121.
TerouanneB., TahiriB., GeorgetV., BelonC., PoujolN., AvancesC., OrioF.Jr., BalaguerP., & SultanC. (2000). A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Molecular and Cellular Endocrinology160, 39–49.
122.
DastonG.P., BainesD., & YonkerJ.E. (1991). Chick embryo neural retina cell culture as a screen for developmental toxicity. Toxicology and Applied Pharmacology109, 352–366.
123.
DastonG.P., BainesD., ElmoreE., FitzgeraldM. P., & SharmaS. (1995). Evaluation of chick embryo neural retina culture as a screen for developmental toxicants. Fundamental and Applied Toxicology26, 203–210.
124.
FengL.X., ChenY., DettinL., PeraR.A., HerrJ.C., GoldbergE., & DymM. (2002). Generation and in vitro differentiation of a spermatogonial cell line. Science, New York297, 392–395.
125.
van PeltA.M., Roepers-GajadienH.L., GademanI.S., CreemersL.B., de RooijD.G., & van Dissel-EmilianiF.M. (2002). Establishment of cell lines with rat spermatogonial stem cell characteristics. Endocrinology143, 1845–1850.
126.
Kanatsu-ShinoharaM., OgonukiN., InoueK., MikiH., OguraA., ToyokuniS., & ShinoharaT. (2003). Long-term proliferation in culture and germline transmission of mouse male germline stem cells. Biology of Reproduction69, 612–616.
127.
KlemmM., GenschowE., PohlI., BarrabasC., LiebschM., & SpielmannH. (2001). Permanent embryonic germ cell lines of BALB/cJ mice: an in vitro alternative for in vivo germ cell mutagenicity tests. Toxicology in Vitro15, 447–453.
128.
DevineP.J., SipesI.G., SkinnerM.K., & HoyerP.B. (2002). Characterization of a rat in vitro ovarian culture system to study the ovarian toxicant 4-vinylcyclohexene diepoxide. Toxicology and Applied Pharmacology184, 107–115.
129.
StaubC., HueD., NicolleJ-C., Perrard-SaporiM-H., SegretainD., & DurandP. (2000). The whole meiotic process can occur in vitro in untransformed rat spermatogenic cells. Experimental Cell Research260, 85–95.
130.
PerrardM-H., HueD., StaubC., Le VernY., KerboeufD., & DurandP. (2003). Development of the meiotic step in testes of pubertal rats: comparison between the in vivo and under in vitro conditions. Molecular Reproduction and Development65, 86–95.
131.
Anon. (2000). The ECVAM Scientific Information Service (SIS) Feasibility Study 1999–2000 on Reproductive Toxicity. European Commission Contract No. 14697-1998-12. 131 pp. Ispra, Italy: ECVAM, European Commission JRC.
132.
MooreH.D., & AkhondiM.A. (1996). In vitro maturation of mammalian spermatozoa. Reviews of Reproduction1, 54–60.
133.
LaskeyJ.W., BermanE., & FerrellJ.M. (1995). The use of cultured ovarian fragments to assess toxicant alterations in steroidogenesis in Sprague-Dawley rat. Reproductive Toxicology9, 131–141.
134.
AmpasavateC., ChandorkarG.A., Vande VeldeD.G., StobaughJ.F., & AudusK.L. (2002). Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. International Journal of Pharmacology233, 85–98.
135.
McAleerM.F., & TuanR.S. (2001). Metallothionein protects against severe oxidative stress-induced apoptosis of human trophoblastic cells. In Vitro Molecular Toxicology14, 219–231.
136.
MaT., YangS.T., & KnissD.A. (1999). Development of an in vitro human placenta model by the cultivation of human trophoblasts in a fiber-based bioreactor system. Tissue Engineering5, 91–102.
137.
Ala-KokkoT.I., PienimakiP., HervaR., HollmenA.I., PelkonenO., & VahakangasK. (1995). Transfer of lidocaine and bupivacaine across the isolated perfused human placenta. Pharmacological Toxicology77, 142–148.
138.
KlimanH.J., FeinbergR.F., & HaimowitzJ.E. (1990). Human trophoblast–endometrial interactions in an in vitro suspension. Placenta11, 349–367.
139.
LiH.Y., ChangS.P., YuanC.C., ChaoH.T., NgH.T., & SungY.J. (2002). Establishment of an efficient method to quantify embryo attachment to endometrial epithelial cell monolayers. In Vitro Cellular and Developmental Biolology — Animal38, 505–511.
140.
HofmannM.C., Van Der WeeK.S., DargartJ.L., DiramiG., DettinL., & DymM. (2003). Establishment and characterization of neonatal mouse sertoli cell lines. Andrologica24, 120–130.
141.
Ambesi-ImpiombatoF.S., ParksL.A.M., & CoonH.G. (1980). Culture of hormone-dependent functional epithelial cells from rat thyroids. Proceedings of the National Academy of Sciences USA77, 3455–3459.
142.
LansM.C., SpiertzC., BrouwerA., & KoemanJ.H. (1994). Different competition of thyroxin binding to transthyretin and thyroxine/binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology270, 129–136.
143.
BrownC.G., FowlerK.L., NichollsP.J., & AtterwillC. (1986). Assessment of thyrotoxicity using in vitro cell culture systems. Food and Chemical Toxicology24, 557–562.
144.
Brucker-DavisR. (1998). Effects of environmental synthetic chemicals on thyroid function. Thyroid8, 827–856.
145.
CortvrindtR., HuY., & SmitzJ. (1998). Recombinant luteinizing hormone as a survival and differentiation factor increases oocyte maturation in recombinant follicle stimulating hormone-supplemented mouse preantral follicle culture. Human Reproduction13, 1292–1302.
146.
DoctermanK.E., & SmithS.M. (2002). Of mice and men: lessons from a microarray study of teratogen action. Teratology66, 217–223.
147.
PennieW.D. (2002). Custom cDNA microarrays; technologies and applications. Toxicology181/182, 551–554.
148.
QinP., CimildoroR., KochharD.M., SopranoK.J., & SopranoD.R. (2002). PBX, MEIS, and IGF-I are potential mediators of retinoic acid-induced proximodistal limb reduction defects. Teratology66, 224–234.
149.
ShultzV.D., PhillipsS., SarM., FosterP.M., & GaidoK.W. (2001). Altered gene profiles in fetal rat testes after in utero exposure to di(n-butyl) phthalate. Toxicological Sciences64, 233–242.
150.
ZurichM.G., EskesCh., HoneggerP., BerodeM., & Monnet-ZschudiF. (2002). Maturation-dependent neurotoxicity of lead acetate in vitro: implication of glial reactions. Journal of Neuroscience Research70, 108–116.
151.
NotterpekL.M., BullockP.N., Maled-HedayatS., FisherR., & RomeL.H. (1993). Myelination in cerebellar slice culture: development of a system amenable to biochemical analysis. Journal of Neuroscience Research36, 621–634.
152.
LeinP.J., SchuhR.A., JettD.A., & BucelliR. (2003). Cultured sympathetic neurons as a model system for investigating the developmental neurotoxicity of organophosphate pesticides. CAAT 20th Anniversary Symposium.1 pp. (abstract). Baltimore, MD, USA: CAAT. Website http://caat.jhsph.edu/programs/workshops/20th/booklet/lein.htm (Accessed 18.10.04).
153.
BurryM., GuizzettiM., OberddoersterJ., & CostaL.G. (2003). Developmental neurotoxicity of toluene: in vivo and in vitro effects on astroglial cells. Developmental Neuroscience25, 14–19.
154.
CooksonM.R., McCleanR., WilliamsS.P., Davenport-JonesJ., O'HareS., Egan, AtterwillC.K., & PentreathV.W. (1994). Use of astrocytes for in vitro neurotoxicity testing. Toxicology in Vitro8, 817–819.
155.
QiaoD., SeidlerF.J., & SlotkinT.A. (2001). Developmental neurotoxicity of chlorpyrifos modeled in vitro: comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environmental Health Perspectives109, 909–913.
156.
LeinP., GoldbergA., LockeP., & SilbergeldE. (2003). In vitro and alternative approaches to developmental neurotoxicity testing.The 9th Meeting of the International Neurotoxicology Association, Dresden, Germany. pp. 141 (abstract). Website http://www.ifado.de/ina-9/INA-9_boa_web.pdf (Accessed 18.10.04).